Quantcast
Many Children With Asthma Food Allergies Lack School

Many Children With Asthma, Food Allergies Lack School Emergency Plans

By Marla Paul, Northwestern University Only one in four students with asthma and half of children with food allergies have emergency health management plans in place at school, leaving schools inadequately prepared to manage daily needs and...

Latest asthma Stories

2014-09-12 04:20:43

LONDON, September 12, 2014 /PRNewswire/ -- Kind Consumer today announced that it has received a product licence for the Company's proprietary nicotine inhaler (Voke Inhaler 0.45mg) for General Sale from the UK Medicines and Healthcare products Regulatory Agency (MHRA). This is a key milestone in the journey towards bringing this important innovation to consumers. The next step will be to submit a variation to the licence to support full-scale commercialisation by our...

2014-09-11 08:27:34

SALT LAKE CITY, Sept. 11, 2014 /PRNewswire-USNewswire/ -- Arches Health Plan announced today that it has partnered with Symptomly to provide a more integrated care strategy to asthmatic members. In the United States there are currently over 25 million Asthmatics, or 1 in every 12 people is suffering from Asthma. Of those, 2.1 million will be admitted to a hospital or emergency room this year. The estimated medical costs for asthmatics patients can be as high as $60 million dollars...

2014-09-11 04:21:18

OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle(TM) (MCP(TM)) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases. The Company...

2014-09-08 12:29:32

For U.S. Media Only RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma(®)) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma. These data were unveiled during an oral session at the European Respiratory Society (ERS) International Congress 2014 in Munich, Germany. Tiotropium is...

2014-09-04 23:10:57

Dr. Anne Marie Salapatek, CSO at Inflamax Research, will be presenting clinical trial data demonstrating the utility of Environmental Exposure Chambers in asthma and allergic rhinitis research at upcoming 2014 European Respiratory Society conference in Munich, Germany, September 6-10. Toronto, ON (PRWEB) September 04, 2014 Inflamax Research Inc., a full-service CRO, announced today that their Chief Science Officer, Dr. Anne Marie Salapatek, will be presenting clinical trial data...

2014-09-04 08:31:03

Company to scale FDA-cleared digital therapeutic to tackle $100 billion cost of treating asthma and chronic obstructive pulmonary disease (COPD) MADISON, Wisc. and WAYNE, Penn., Sept. 4, 2014 /PRNewswire/ -- Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced that it raised $14.5 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership....

2014-09-02 08:29:36

MONROVIA, Calif., Sept. 2, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced the appointment of Debra Zack, M.D., Ph.D., vice president, clinical development and the appointment of Lloyd Rowland, senior vice president, chief compliance officer and general counsel. "Debra's expertise in biologics...

2014-09-02 04:21:24

QXFORD, England, September 2, 2014 /PRNewswire/ -- Triggers milestone payment from Mylan Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that its Marketing Authorisation Application (MAA) for PSX1001 has been validated and is being assessed under the Decentralised Procedure (DCP), in which the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is...

asthma mold
2014-08-31 05:25:06

Rayshell Clapper for redOrbit.com - Your Universe Online The allergen and fungi mold is gross. It looks gross in its variety of colors. It grows in typically gross places (around toilet bowls, under sinks, in nooks and crannies). It feels gross and slimy if one happens to accidentally touch it. And frankly, it can smell pretty gross. When we walk into a place that has a plethora of mold, our noses tell us right away. Yes, mold is gross. And it is dangerous. There are types of molds...

2014-08-21 12:25:49

Efficacy on Reducing Exacerbations and Hospitalizations is One of the Key Drug Attributes for Formulary Inclusion, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the asthma market in Brazil and Mexico currently faces severe coverage restrictions. The uptake of several newly approved agents, the anticipated label extension of Boehringer Ingelheim/Pfizer's Spiriva for this indication and the launch of...


Latest asthma Reference Libraries

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

More Articles (1 articles) »
Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related